top of page
Newspapers

NEWS & EVENTS

Brooks Hill Partners Joins Financing for Astrocyte Pharmaceuticals

  • Writer: Brooks Hill Partners
    Brooks Hill Partners
  • Apr 1, 2017
  • 1 min read

Updated: Dec 19, 2023

Brooks Hill Partners has added Astrocyte Pharmaceuticals to their portfolio. This drug development company is dedicated to using the neuroprotective benefits of selective astrocyte activation to create novel therapies for brain injury patients.



Learn more about Astrocyte here.

Brooks Hill Partners is a life sciences consultancy and early-stage health tech venture capital firm that partners with passionate companies across the biopharma and healthcare landscape. Please contact us to learn more about how we can help you today. For more information, visit https://www.brookshillpartners.com/ and follow us on LinkedIn.  

Comentarios


Ya no es posible comentar esta entrada. Contacta al propietario del sitio para obtener más información.

Interested in learning more?

Are you a health tech founder?

bottom of page